INTUITIVE SURGICAL INC (ISRG)
US46120E6023 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.71B 31.01% | 6.222B 8.97% | 7.124B 14.49% | 8.305B 16.58% | 9.706B 16.87% | 11.227B 15.67% | 12.517B 11.49% | 14.201B 13.45% | 15.487B 9.06% | 17.462B 12.75% | 16.2B -7.23% | |
| EBITDA YoY % growth | 2.164B 59.27% | 1.99B -8.06% | 2.235B 12.33% | 3.436B 53.73% | 4.072B 18.51% | 4.741B 16.43% | 5.415B 14.22% | 6.69B 23.55% | 7.498B 12.08% | 8.724B 16.35% | N/A | |
| EBIT YoY % growth | 1.832B 71.93% | 1.597B -12.81% | 1.78B 11.45% | 2.942B 65.25% | 3.471B 17.98% | 4.138B 19.22% | 4.796B 15.90% | 5.706B 18.97% | 6.611B 15.86% | 7.703B 16.52% | N/A | |
| Operating Margin | 32.09% | 25.67% | 24.99% | 35.42% | 35.76% | 36.86% | 38.32% | 40.18% | 42.69% | 44.11% | N/A | |
| EPS YoY % growth | 4.97 46.90% | 4.69 -5.63% | 5.71 21.75% | 7.02 23.02% | 8.03 14.27% | 9.40 17.16% | 10.82 15.08% | 12.66 16.99% | 14.87 17.45% | 17.26 16.05% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.79 12.18% | 1.81 20.76% | 2.01 13.04% | 2.06 11.82% | 2.11 17.29% | 2.06 13.75% | 2.33 15.58% | 2.40 16.75% | 2.46 16.77% |
| Revenue Q2Q % growth | 2.245B 16.42% | 2.24B 18.48% | 2.383B 18.56% | 2.432B 19.33% | 2.608B 16.17% | 2.563B 14.42% | 2.736B 14.81% | 2.791B 14.76% | 2.987B 14.53% |
| EBITDA Q2Q % growth | 894.35M -1.45% | 917.07M 56.04% | 1.006B 24.71% | 1.037B 10.07% | 1.075B 20.20% | 1.111B 21.15% | 1.19B 18.29% | 1.253B 20.83% | 1.358B 26.33% |
| EBIT Q2Q % growth | 755.79M 66.95% | 779.83M 65.96% | 864.26M 52.16% | 887.61M 53.62% | 912.43M 20.73% | 899.78M 15.38% | 1.01B 16.86% | 1.034B 16.49% | 1.079B 18.26% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.84 26.03% | 1.67 | 0.17 | 10.37% |
| Q2 2024 Q2Q % growth | 1.78 25.35% | 1.57 | 0.21 | 13.38% |
| Q1 2024 Q2Q % growth | 1.50 21.95% | 1.44 | 0.06 | 4.44% |
| Q4 2023 Q2Q % growth | 1.60 30.08% | 1.51 | 0.09 | 5.71% |
| Q3 2023 Q2Q % growth | 1.46 22.69% | 1.44 | 0.02 | 1.36% |
| Q2 2023 Q2Q % growth | 1.42 24.56% | 1.35 | 0.07 | 4.99% |
| Q1 2023 Q2Q % growth | 1.23 8.85% | 1.22 | 0.01 | 0.47% |
| Q4 2022 Q2Q % growth | 1.23 -5.38% | 1.28 | -0.05 | -3.59% |
| Q3 2022 Q2Q % growth | 1.19 | 1.14 | 0.05 | 4.23% |
| Q2 2022 Q2Q % growth | 1.14 -12.76% | 1.21 | -0.07 | -5.83% |
| Q1 2022 Q2Q % growth | 1.13 -3.69% | 1.10 | 0.03 | 2.71% |
| Q4 2021 Q2Q % growth | 1.30 8.94% | 1.30 | 0.00 | -0.36% |
| Q3 2021 Q2Q % growth | 1.19 28.88% | 1.19 | 0.00 | 0.04% |
| Q2 2021 Q2Q % growth | 1.31 253.15% | 1.04 | 0.26 | 25.38% |
| Q1 2021 Q2Q % growth | 1.17 30.85% | 0.90 | 0.28 | 31.07% |
| Q4 2020 Q2Q % growth | 1.19 2.87% | 1.06 | 0.13 | 12.35% |
| Q3 2020 Q2Q % growth | 0.92 -19.24% | 0.70 | 0.22 | 31.36% |
| Q2 2020 Q2Q % growth | 0.37 -65.85% | 0.15 | 0.22 | 152.48% |
| Q1 2020 Q2Q % growth | 0.90 3.07% | 0.87 | 0.03 | 3.65% |
| Q4 2019 Q2Q % growth | 1.16 11.54% | 1.15 | 0.01 | 1.03% |
| Q3 2019 Q2Q % growth | 1.14 21.20% | 1.02 | 0.13 | 12.42% |
| Q2 2019 Q2Q % growth | 1.08 17.75% | 0.98 | 0.11 | 10.98% |
| Q1 2019 Q2Q % growth | 0.87 6.97% | 0.92 | -0.05 | -5.22% |
| Q4 2018 Q2Q % growth | 1.04 | 1.04 | 0.00 | -0.39% |
| Q3 2018 Q2Q % growth | 0.94 | 0.91 | 0.04 | 4.23% |
| Q2 2018 Q2Q % growth | 0.92 | 0.85 | 0.07 | 8.43% |
| Q1 2018 Q2Q % growth | 0.81 | 0.70 | 0.11 | 15.48% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 2.038B 16.88% | 2.041B | -2.9M | -0.14% |
| Q2 2024 Q2Q % growth | 2.01B 14.47% | 2.011B | -1.1M | -0.05% |
| Q1 2024 Q2Q % growth | 1.891B 11.46% | 1.905B | -14.4M | -0.76% |
| Q4 2023 Q2Q % growth | 1.928B 16.51% | 1.926B | 2.3M | 0.12% |
| Q3 2023 Q2Q % growth | 1.744B 11.96% | 1.802B | -58.3M | -3.24% |
| Q2 2023 Q2Q % growth | 1.756B 15.36% | 1.774B | -18.1M | -1.02% |
| Q1 2023 Q2Q % growth | 1.696B 14.01% | 1.628B | 68.2M | 4.19% |
| Q4 2022 Q2Q % growth | 1.655B 6.73% | 1.702B | -47M | -2.76% |
| Q3 2022 Q2Q % growth | 1.557B 10.98% | 1.547B | 10.4M | 0.67% |
| Q2 2022 Q2Q % growth | 1.522B 3.97% | 1.592B | -69.9M | -4.39% |
| Q1 2022 Q2Q % growth | 1.488B 15.14% | 1.455B | 32.7M | 2.25% |
| Q4 2021 Q2Q % growth | 1.551B 16.67% | 1.552B | -1.3M | -0.08% |
| Q3 2021 Q2Q % growth | 1.403B 30.21% | 1.413B | -9.7M | -0.69% |
| Q2 2021 Q2Q % growth | 1.464B 71.81% | 1.29B | 174M | 13.49% |
| Q1 2021 Q2Q % growth | 1.292B 17.52% | 1.135B | 157.1M | 13.84% |
| Q4 2020 Q2Q % growth | 1.329B 4.02% | 1.264B | 65.1M | 5.15% |
| Q3 2020 Q2Q % growth | 1.078B -4.48% | 990.39M | 87.31M | 8.82% |
| Q2 2020 Q2Q % growth | 852.1M -22.46% | 687.28M | 164.82M | 23.98% |
| Q1 2020 Q2Q % growth | 1.1B 12.92% | 1.049B | 50.5M | 4.81% |
| Q4 2019 Q2Q % growth | 1.278B 22.09% | 1.263B | 14.7M | 1.16% |
| Q3 2019 Q2Q % growth | 1.128B 22.51% | 1.086B | 42.2M | 3.89% |
| Q2 2019 Q2Q % growth | 1.099B 20.85% | 1.053B | 45.9M | 4.36% |
| Q1 2019 Q2Q % growth | 973.7M 14.89% | 992.9M | -19.2M | -1.93% |
| Q4 2018 Q2Q % growth | 1.047B | 1.058B | -11.5M | -1.09% |
| Q3 2018 Q2Q % growth | 920.9M | 935.43M | -14.53M | -1.55% |
| Q2 2018 Q2Q % growth | 909.3M | 894.19M | 15.11M | 1.69% |
| Q1 2018 Q2Q % growth | 847.5M | 794.51M | 52.99M | 6.67% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.05% | 5.55% | -0.02% | 3.61% |
| Revenue | 0% | 1.31% | -0.05% | 0.63% |